202 related articles for article (PubMed ID: 30216683)
21. A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia.
Adeyemo TA; Ojewunmi OO; Oyetunji IA; Rooks H; Rees DC; Akinsulie AO; Akanmu AS; Thein SL; Menzel S
PLoS One; 2018; 13(6):e0197927. PubMed ID: 29879141
[TBL] [Abstract][Full Text] [Related]
22. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
J Genet; 2024; 103():. PubMed ID: 38736250
[TBL] [Abstract][Full Text] [Related]
23. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants associated with fetal hemoglobin levels show the diverse ethnic origin in Colombian patients with sickle cell anemia.
Fong C; Menzel S; Lizarralde MA; Barreto G
Biomedica; 2015; 35(3):437-43. PubMed ID: 26849705
[TBL] [Abstract][Full Text] [Related]
25. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
[TBL] [Abstract][Full Text] [Related]
26. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
[TBL] [Abstract][Full Text] [Related]
27. Existence of HbF Enhancer Haplotypes at
Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
[No Abstract] [Full Text] [Related]
28. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
[TBL] [Abstract][Full Text] [Related]
29. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia
Heitzer AM; Longoria J; Rampersaud E; Rashkin SR; Estepp JH; Okhomina VI; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Hankins JS
Curr Res Transl Med; 2022 Jul; 70(3):103335. PubMed ID: 35303690
[TBL] [Abstract][Full Text] [Related]
30. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
[TBL] [Abstract][Full Text] [Related]
31. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
Allard P; Alhaj N; Lobitz S; Cario H; Jarisch A; Grosse R; Oevermann L; Hakimeh D; Tagliaferri L; Kohne E; Kopp-Schneider A; Kulozik AE; Kunz JB
Haematologica; 2022 Jul; 107(7):1577-1588. PubMed ID: 34706496
[TBL] [Abstract][Full Text] [Related]
32. Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions.
Pule GD; Ngo Bitoungui VJ; Chetcha Chemegni B; Kengne AP; Antonarakis S; Wonkam A
OMICS; 2015 Oct; 19(10):627-31. PubMed ID: 26393293
[TBL] [Abstract][Full Text] [Related]
33. Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
Leonardo FC; Brugnerotto AF; Domingos IF; Fertrin KY; de Albuquerque DM; Bezerra MA; Araújo AS; Saad ST; Costa FF; Menzel S; Conran N; Thein SL
Br J Haematol; 2016 May; 173(3):456-60. PubMed ID: 26888013
[TBL] [Abstract][Full Text] [Related]
34. The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β(0) -thalassaemia homozygotes.
Jiang Z; Luo HY; Huang S; Farrell JJ; Davis L; Théberge R; Benson KA; Riolueang S; Viprakasit V; Al-Allawi NA; Ünal S; Gümrük F; Akar N; Başak AN; Osorio L; Badens C; Pissard S; Joly P; Campbell AD; Gallagher PG; Steinberg MH; Forget BG; Chui DH
Br J Haematol; 2016 Mar; 172(6):958-65. PubMed ID: 26771086
[TBL] [Abstract][Full Text] [Related]
35. The Impact of XmnI-HBG2, BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms on Hb F Variation of Hematologically Normal Iranian Individuals.
Keyhani E; Jafari Vesiehsari M; Talebi Kakroodi S; Darabi E; Zamani F; Karimlou M; Kamali K; Neishabury M
Hemoglobin; 2016 Jun; 40(3):198-201. PubMed ID: 27117569
[TBL] [Abstract][Full Text] [Related]
36. Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach.
Fanis P; Kousiappa I; Phylactides M; Kleanthous M
BMC Genomics; 2014 Feb; 15():108. PubMed ID: 24502199
[TBL] [Abstract][Full Text] [Related]
37. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
[TBL] [Abstract][Full Text] [Related]
38. Discovering the genetics underlying foetal haemoglobin production in adults.
Thein SL; Menzel S
Br J Haematol; 2009 May; 145(4):455-67. PubMed ID: 19344402
[TBL] [Abstract][Full Text] [Related]
39. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
Menzel S; Thein SL
Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
[TBL] [Abstract][Full Text] [Related]
40. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
